ArticleMolecular therapy. Methods & clinical development2014

Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.

Masanori Matsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.